The Cutting Edge Webinar Series

Starts February 25th, 2025

Episode 1

MMR and Other Tumour-Agnostic Biomarkers – Unraveling Implementation Challenges

Date: Tuesday February 25th, 2025 – 12:00pm – 1:30pm (EST)

Speaker

Carol C. Cheung

Carol C. Cheung MD, PhD, JD, FRCPC
Carol Cheung is Deputy Director of Canadian Biomarker Quality Assurance.

For any questions about the Webinar series content, feel free to reach out to me at carol.cheung@cbqa.ca


Mary Kinloch

Mary Kinloch MD, FRCPC
Saskatoon, Saskatchewan
Clinical Associate Professor, University of Saskatchewan

Dr. Kinloch is a practicing gynecologic pathologist and the Area Department Lead of Pathology and Laboratory Medicine in Saskatoon on Treaty 6 territory.

Provincially she sits as co-chairs for Biomarker Development and Quality Assurance Committee and Cervical Cancer Screening task force in Saskatchewan.

Nationally she is on the Board of Directors for the Canadian Association of Pathologists, the pathologist representative for CCTG’s EN.10 clinical trial, and internationally is on the International Association of Pathology’s Education Committee.

Her research interests include the effects of precision molecular classification of ovarian and endometrial cancer in the variation of oncologic treatment and bringing complete genomic profiling of ovarian cancer.

Learning Objectives:

After this episode, the participant will be able to:

  1. List two tumour agnostic biomarkers that are relevant to Canadian precision diagnostics.
  2. Outline two strategies to overcome challenges for implementing tumour- agnostic biomarker testing.